| Cat.No. | Name | Information |
|---|---|---|
| M8975 | CWHM-12 | CWHM-12 is a potent inhibitor of αV integrins with IC50 values of 0.2, 0.8, 1.5, and 1.8 nM for αvβ8, αvβ3, αvβ6, and αvβ1, respectively. |
| M9173 | Cilengitide trifluoroacetate | Cilengitide is a potent integrin inhibitor for αvβ3 and αvβ5 receptor with IC50 of 4.1 nM, 79 nM in cell-free assays respectively. |
| M2042 | Cilengitide | Cilengitide (EMD 121974, NSC 707544) is a selective inhibitor of αvβ3 integrin and αvβ5 integrin with IC50 of 1 nM and 140 nM, respectively. |
| M10728 | Cyclo(RGDyK) trifluoroacetate | Cyclo(RGDyK) trifluoroacetate is an effective selectivity αVβ3 integrin inhibitors,IC50 20 nM. |
| M10636 | Echistatin TFA | Echistatin TFA is a potent inhibitor of platelet aggregation. Echistatin is a potent inhibitor of bone resorption in culture. Echistatin is a potent antagonist of αIIbβ3, αvβ3 and α5β1. |
| M10557 | RGD peptide (GRGDNP) (TFA) | RGD peptide TFA acts as an inhibitor of integrin-ligand interactions and plays an important role in cell adhesion, migration, growth, and differentiation. |
| M10480 | Tetraiodothyroacetic acid (tetrac) | Tetraiodothyroacetic acid (tetrac) is a thyrointegrin receptor antagonist. Tetraiodothyroacetic acid blocks the actions of T4 and 3,5,3'-triiodo-L-thyronine (T3) at the cell surface receptor for thyroid hormone on integrin αvβ3. |
| M10211 | Obtustatin | Obtustatin is a potent integrin α1β1 inhibitor with IC50 of 0.8 nM for α1β1 binding to type IV collagen. |
| M10209 | Cyclo(-RGDfK) | Cyclo (-RGDfK) is an effective and specific αvβ3 integrin inhibitor. |
| M9781 | E7820 | E7820 is a α2 integrin inhibitor which suppressing integrin alpha 2, a cell adhesion molecule expressed on endothelial cells. |
| M8939 | Firategrast | Firategrast (SB-683699) is an orally bioavailable alpha4 beta1/alpha4 beta7 integrin antagonist. |
| M7384 | TCS 2314 | TCS 2314 is a α 4β 1 (VLA-4) antagonist. |
| M6905 | Leukadherin 1 | Leukadherin 1 is a allosteric activator of CD11b/CD18. |
| M6538 | BTT 3033 | BTT 3033 is a selective inhibitor of integrin α 2β 1. |
| M6363 | A 286982 | A 286982 is a potent inhibitor of the LFA-1/ICAM-1 interaction. |
| M6018 | Tirofiban hydrochloride monohydrate | Tirofiban hydrochloride monohydrate is a potent non-peptide, glycoprotein IIb/IIIa (integrins alphaIIbbetaIII) antagonist |
| M5852 | Lifitegrast | Lifitegrast is an antagonist of integrin lymphocyte function associated antigen-1 (LFA-1). The IC50 of Jurkat T cells to icAM-1 was 2.98nM. Lifitegrast blocks the interaction between LFA-1 and ICAM-1, thereby reducing T cell activity and cytokine secretion. |
| M5619 | Eptifibatide | Eptifibatide is an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class. |
| M5241 | GLPG0187 | GLPG0187 inhibited the progression of bone metastasis. Maximum efficacy of inhibition of bone metastasis was achieved when GLPG0187 was combined with the standard-of-care metastatic breast cancer treatments. |
| M4616 | Cucurbitacin-B | Cucurbitacin B is a natural compound with anticancer activity. |
| M3789 | ATN-161 TFA | ATN-161 TFA salt is a novel small peptide inhibitor of integrin α5β1; a beta integrin antagonist with antitumor activity. |
| M3074 | Tirofiban | Tirofiban (MK-383) is a selective palate GPIIb/IIIa antagonist which inhibits platelet aggregation with IC50 of 9 nM. |
| M2976 | RGD | RGD (Arg-Gly-Asp) Peptides is a cell adhesion motif which can mimic cell adhesion proteins and bind to integrins. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
